Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer
NCT02118077 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 154
Last updated 2014-04-21
Summary
Compare the effect of G17DT with that of placebo on the survival of subjects with advanced pancreatic cancer.
Conditions
Interventions
- BIOLOGICAL
-
G17DT
Sponsors & Collaborators
-
Cancer Advances Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-04-30
- Primary Completion
- 2004-04-30
More Related Trials
-
Adavosertib and Gemcitabine in Advanced Pancreatic
NCT05212025 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas
NCT03779464 ·Status: UNKNOWN ·Phase: PHASE2
-
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery
NCT02194829 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic Carcinoma
NCT00177242 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer
NCT00553813 ·Status: TERMINATED ·Phase: PHASE2
-
Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer
NCT00005648 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma
NCT01146054 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
NCT01303172 ·Status: COMPLETED ·Phase: PHASE2
-
An Open, Single-center Study to Determine the Antibody Repsonse to Gastrimmune and Its Safety and Tolerability in Patients With Advanced Pancreatic Carcinoma
NCT02098291 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2, Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Metastatic Pancreatic Cancer
NCT02570711 ·Status: TERMINATED ·Phase: PHASE2
-
Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer
NCT02135822 ·Status: UNKNOWN ·Phase: PHASE2
-
A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer
NCT04624217 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer
NCT00026403 ·Status: COMPLETED ·Phase: PHASE2
-
Antigen-specific Cancer Immunotherapy (TG01) and Gemcitabine as Adjuvant Therapy in Resected Pancreatic Cancer
NCT02261714 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
NCT02101021 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer
NCT02017015 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas
NCT00005926 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
NCT00003546 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
NCT00810719 ·Status: COMPLETED ·Phase: PHASE2
-
Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer
NCT02124317 ·Status: UNKNOWN ·Phase: PHASE2
-
Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer
NCT00191568 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer
NCT02210559 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer
NCT00025168 ·Status: COMPLETED ·Phase: PHASE2
-
Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
NCT01783171 ·Status: COMPLETED ·Phase: PHASE1
-
PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma
NCT00226005 ·Status: COMPLETED ·Phase: PHASE2